MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'hpv vaccine'. Sat, 03 Sep 2011 01:58:38 +0100 http://www.medworm.com/index.php?rid=4540567&cid=t_91822_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fnew-study-links-hpv-to-head-and-neck-cancers-in-men%2F2011.03.02 A new study finds that half of men in America are infected with the HPV virus. Dr. Jon LaPook reports on the growing concern that the virus in men could be responsible for an increase in head and neck cancers. HPV Affects Half Of U.S. Men A study out [yesterday] in The Lancet by Moffitt Cancer Center researcher Anna Giuliano, Ph.D., and her colleagues finds that 50 percent of men ages 18 to 70 in Brazil, Mexico, and the U.S. have genital infection with human papillomavirus (HPV).  HPV is the virus that causes cervical cancer in women. It also causes warts and cancer of the genitals and anus in both men and women. Over the past several years, researchers have realized that the virus can also cause cancer of the head and neck. Aimee R. Kreimer, Ph.D., of the National Cancer Institute, ... Better Health blogs http://www.medworm.com/rss/comments.php?id=4540567 Wed, 02 Mar 2011 16:00:34 +0100 4540567 http://www.medworm.com/index.php?rid=4433105&cid=t_91822_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fthe-link-between-oral-sex-and-head-and-neck-cancer%2F2011.02.03 USA Today published a pretty accurate article regarding the rise of certain head and neck cancers with the increased popularity of oral sex and number of sexual partners. The factor that creates this link is the human papillomavirus (HPV) which is associated with tonsil and tongue cancer. Alcohol and tobacco use is more highly linked with such oral cancers, but HPV does appear to be an independent risk factor. A 2007 study in the New England Journal of Medicine found that younger people with head and neck cancers who tested positive for oral HPV infection were more likely to have had multiple vaginal and oral sex partners in their lifetime. Having six or more oral sex partners over a lifetime was associated with a 3.4 times higher risk for oropharyngeal cancer — cancers of the base ... Better Health blogs http://www.medworm.com/rss/comments.php?id=4433105 Thu, 03 Feb 2011 14:00:00 +0100 4433105 http://www.medworm.com/index.php?rid=4372213&cid=t_91822_136_f&fid=37846&url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2011%2F01%2F19%2Flibbys-hope%25e2%2584%25a2-proudly-announces-a-strategic-partnership-with-womens-oncology-research-dialogue%2F It is our privilege and honor to announce a strategic partnership between Libby’s H*O*P*E*™ and Women’s Oncology Research & Dialogue. It is our privilege and honor to announce a strategic partnership between Libby’s H*O*P*E*™ (LH) and Women’s Oncology Research & Dialogue (WORD). WORD’s overarching mission is to raise gynecologic cancer awareness and fund related scientific [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=4372213 Thu, 20 Jan 2011 01:22:53 +0100 4372213 http://www.medworm.com/index.php?rid=4295015&cid=t_91822_160_f&fid=38218&url=http%3A%2F%2Fwaronwarts.com%2Fgenital-warts%2Fhpv%2Fnew-york%2Flong-island%2Fgeneral-info%2Ffda-approves-hpv-vaccine-for-men%2F Gardasil (human papillomavirus vaccine), the vaccine that can prevent most cases of cervical cancer in girls, has won the FDA’s blessing as a vaccine to prevent anal cancer, a huge victory for men! The FDA’s  approval for Gardasil as an anal cancer vaccine opens the way for the medication’s maker, Merck and Co. Inc., to market the vaccine to boys and young men between the ages of nine and 26 – an option that will be most meaningful for men who have sex with men, but valuable to all.  Nobody likes getting HPV on their penis.  It really can devastate many boys and men.  When the HPV ends up on their anal area – the risk of anal cancer is high.  Although this is most commonly seen in homosexual men, it is not infrequent for heterosexual men to be at risk.  ... War On Warts blogs http://www.medworm.com/rss/comments.php?id=4295015 Mon, 27 Dec 2010 18:02:50 +0100 4295015 http://www.medworm.com/index.php?rid=4258863&cid=t_91822_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fskin-cancer-where-the-sun-don%25e2%2580%2599t-shine%2F2010.12.14 Not all skin cancers are from sun exposure. Viruses such as human papilloma virus (HPV), the virus that causes genital warts, also cause skin cancer. Skin cancer from HPV develops on genital skin in both men and women. It’s rarely talked about, but it’s important and can be deadly. Did you know that half of all deaths from skin cancer other than melanoma are from genital skin cancer? You probably also didn’t know that women are more likely to die from genital skin cancer as they are from skin cancer that developed from sun exposure (again, excluding melanoma). We dermatologists are inexhaustible when it comes to warning people about the dangers of sun exposure, but we should also be warning people about the dangers of genital warts. HPV protection, which includes HPV vaccines, ... Better Health blogs http://www.medworm.com/rss/comments.php?id=4258863 Tue, 14 Dec 2010 23:00:03 +0100 4258863 http://www.medworm.com/index.php?rid=4121859&cid=t_91822_87_f&fid=39261&url=http%3A%2F%2Fvactruth.com%2F2010%2F10%2F30%2Fletter-alerts-obama-to-dangers-of-hpv-vaccines%2F In an extraordinary move to prevent further HPV vaccine casualties, Marian Greene the Chairwomen and Co-Founder of the campaign and action group Truth about Gardasil (http://truthaboutgardasil.org/), has written an open letter to President Obama.  Her letter urges the President to take time to research the HPV vaccines Gardasil and Cervarix and to read what is happening to the innocent young men and women of America. She opens her letter by saying: “We come to you now to beg for your help. The lives of an entire generation of young women and now, men, are hanging in the balance.” Greene strengthens her plea by alerting the President to a staggering 20101 reports of injury and 84 deaths; highlighting the case of a forty day old baby who died after being exposed to Gardasil through the ... vactruth.com blogs http://www.medworm.com/rss/comments.php?id=4121859 Sat, 30 Oct 2010 15:01:49 +0100 4121859 http://www.medworm.com/index.php?rid=3212393&cid=t_91822_109_f&fid=36089&url=http%3A%2F%2Fthesituationist.wordpress.com%2F2010%2F01%2F27%2Fdan-kahan-on-the-situation-of-risk-perceptions%2F Situationist Contributor Dan Kahan was recently interviewed for the National Science Foundation website.  In the interview, which you can watch the on the video below, Kahan discusses how people’s values shape perceptions of the HPV vaccine.  Here’s the abstract. * * * The “cultural cognition thesis” argues that individuals form risk perceptions based on often-contested personal views about what makes a good society. Now, Yale University Law professor Dr. Dan Kahan and his colleagues reveals how people’s values shape their perceptions of one of the most hotly debated health care proposals in recent years: vaccinating elementary-school girls, ages 11-12, against human papillomavirus (HPV), a widespread sexually transmitted disease. * * * * * * For a sam... The Situationist blogs http://www.medworm.com/rss/comments.php?id=3212393 Wed, 27 Jan 2010 04:01:46 +0100 3212393 http://www.medworm.com/index.php?rid=3149008&cid=t_91822_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2010%2F01%2F07%2Fcervical-cancer-month%2F Filed under: Prevention, Cervical CancerThe National Cervical Cancer Coalition launched a campaign against the Human Papillomavirus (HPV), the virus that can cause cervical cancer, this month. Once the number one cancer killer of women, cervical cancer is the only cancer known to be caused by a common virus. According to the Centers for Disease Control and Prevention (CDC), nearly 4,000 women in America die of cervical cancer every year; and, an estimated 12,000 new cases are diagnosed in the U.S. annually. Most women become infected with HPV in their teens, 20s or 30s; but, it can take nearly two more decades for cancer to develop. During that time, regular Pap tests can detect HPV-related cell changes before they become cancerous. The American College of Obstetricians and Gynecologi... The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=3149008 Thu, 07 Jan 2010 00:00:00 +0100 3149008 http://www.medworm.com/index.php?rid=3008046&cid=t_91822_87_f&fid=34872&url=http%3A%2F%2Fwww.blisstree.com%2Fhealthbolt%2Fhpv-vacc-no-longer-a-must-u-s-immigrants%2F There was a huge uproar among women’s groups and immigration groups when news got out that the vaccine against some strains of human papillomavirus, which cause genital warts and may contribute to the development of cancer of the cervix, would be mandatory for any woman who wants to come to the United States to live permanently. What caused this uproar? The same requirement was not place on women who were American citizens. Granted, the United States has the right to make its own rules regarding what vaccinations people must have if they want to live within the U.S. borders. But, this isn’t a case of someone who may bring in a disease or someone living in a less prosperous country who may not have had the vaccines that we take for granted in North America. In the eyes of many, ... Healthbolt blogs http://www.medworm.com/rss/comments.php?id=3008046 Thu, 19 Nov 2009 11:33:18 +0100 3008046 http://www.medworm.com/index.php?rid=2855666&cid=t_91822_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FEGWTLO6RZJg%2F Whether you agree with the new HPV (human papillomavirus) vaccines or not, one has to be fair about the news that comes out about it. Last week, it was widely reported that a 14-year-old British girl died after receiving the Cervarix vaccine. This vaccine is being given to young women and adolescent girls to reduce the risk of contracting some types of HPV, which are known to cause a significant number of cervical cancer cases. Sadly, Natalie, the 14-year-old, became ill shortly after being vaccinated and she died not long after. Of course, it wasn’t hard not to blame the vaccine as it certainly appeared that the cause and effect was there. But after examining Natalie’s body, doctors confirmed that her death was not due to the vaccine, but rather that, Natalie had an undetected... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2855666 Fri, 02 Oct 2009 14:33:02 +0100 2855666 http://www.medworm.com/index.php?rid=2090935&cid=t_91822_160_f&fid=38218&url=http%3A%2F%2Fwaronwarts.com%2F2008%2F11%2Fa-vaccine-for-boys-to-help-girls%2F As a parent of a school-age daughter, I haven’t decided what to think about the new cervical cancer vaccine. That’s why I was interested to learn the shot may soon be given to boys primarily to benefit girls. Merck’s Gardasil vaccine is approved for use in girls and women, ages 9 to 26, to protect them against the human papillomavirus, or H.P.V., which causes cervical cancer. Girls can be vaccinated when they are as young as 9, although it’s recommended for 11- and 12-year-olds, before they are sexually active. But as my colleague Jan Hoffman reported yesterday in the Sunday Style section of The Times, the vaccine could be approved by 2009 for boys as well. Although Gardasil also protects against genital warts, which are not life-threatening, the primary reason to extend approval ... War On Warts blogs http://www.medworm.com/rss/comments.php?id=2090935 Sat, 29 Nov 2008 01:51:35 +0100 2090935 http://www.medworm.com/index.php?rid=1696501&cid=t_91822_109_f&fid=36089&url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F08%2F11%2Fthe-cultural-situation-of-the-hpv-vaccine%2F Situationist Contributors Dan Kahan, Geoffrey Cohen, and Paul Slovic and their coauthors Donald Braman, and John Gastil, recently posted a fascinating paper, “Who Fears the HPV Vaccine, Who Doesn’t, and Why? An Experimental Study of the Mechanisms of Cultural Cognition” on SSRN. Here’s the abstract. * * * The cultural cognition hypothesis holds that individuals are disposed to form risk perceptions that reflect and reinforce their commitments to contested views of the good society. This paper reports the results of a study that used the controversy over mandatory HPV vaccination to test the cultural cognition hypothesis. Although public health officials have recommended that all girls aged 11 or 12 be vaccinated for HPV - a virus that causes cervical cancer and tha... The Situationist blogs http://www.medworm.com/rss/comments.php?id=1696501 Tue, 12 Aug 2008 00:15:54 +0100 1696501 http://www.medworm.com/index.php?rid=1593719&cid=t_91822_87_f&fid=34825&url=http%3A%2F%2Fwww.wesleyjsmith.com%2Fblog%2F2008%2F07%2Fhpv-vaccine-update-dangerous-to-girls.html Readers of SHS will recall when the HPV vaccine first came out and with it, a great political push made by business interests and those of a certain cultural persuasion that expected (wanted?) teenage girls to be sexually active to require all girls to receive the vaccine. That effort stalled, and from my perspective, that's a good thing on several levels. One is that the vaccine may have serious side effects. From the story:Ault explains why youth is key. Human papillomavirus is sexually transmitted, "so one of the advantages of giving it to adolescents is that they are unlikely to have been sexually active, so they will not have been exposed to the virus before getting the vaccine." Another reason to do this early, Ault points out, is that "our immune system is a lot better when we are 1... Secondhand Smoke blogs http://www.medworm.com/rss/comments.php?id=1593719 Mon, 07 Jul 2008 12:00:00 +0100 1593719 http://www.medworm.com/index.php?rid=1556509&cid=t_91822_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F323346511%2F As a result, the Cervarix vaccine may not become available until mid or late 2009, at the earliest. You may recall that, last December, the FDA issued a so-called ‘complete response letter’ for Glaxo’s HPV vaccine, which would compete with Merck’s Gardasil, but it was unclear at the time whether additional clinical trials would be required. Today, the drugmaker says new clinical studies are not expected to be required for approval, but other data will submitted. Specifically, this would be final data from a Phase III pivotal efficacy study, which should be available later this year and submitted to the FDA in the first half of 2009, although exact timing is hard to predict. And with another six-month review period, Cervarix won’t be on the market until late 2009, at t... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1556509 Mon, 30 Jun 2008 13:27:25 +0100 1556509 http://www.medworm.com/index.php?rid=1401385&cid=t_91822_87_f&fid=35052&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FWomensBioethicsBlog%2F%7E3%2F278270428%2Fadding-to-our-collection-of-posts-about.html Adding to our collection of posts about Gardasil and the HPV vaccine is the news that HPV is one of two viral links to lung cancer. Two new studies suggest that viruses - specifically, HPV and... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] (Source: Women's Bioethics Blog) Women's Bioethics Blog blogs http://www.medworm.com/rss/comments.php?id=1401385 Sat, 26 Apr 2008 13:21:18 +0100 1401385 http://www.medworm.com/index.php?rid=1215323&cid=t_91822_87_f&fid=35052&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FWomensBioethicsBlog%2F%7E3%2F230866038%2Fshould-hpv-vaccine-be-mandated.html We've discussed the HPV vaccine and why we think it should (or should not) be a mandatory vaccination - for both women and men (an argument we were making long before last week's study showed... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] (Source: Women's Bioethics Blog) Women's Bioethics Blog blogs http://www.medworm.com/rss/comments.php?id=1215323 Thu, 07 Feb 2008 14:22:39 +0100 1215323 http://www.medworm.com/index.php?rid=1215497&cid=t_91822_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F230982477%2F Sanofi-Pasteur is criticizing Glaxo’s new Cervarix in an attempt to bolster its lead in the burgeoning market for HPV vaccines, The Financial Times writes. The vaccine maker, which sells Merck’s Gardasil in Europe, has been wooing investors this week with presentations claiming greater proven health benefits from Gardasil in preventing human papilloma virus infections, which is the leading cause of cervical cancer. Didier Hoch, who heads a joint venture between Sanofi-Aventis and Merck for European vaccine marketing, says published Glaxo results on Cervarix were less conclusive and dismissed as “a marketing gimmick” a clinical study that directly compares the two products. He lambasted the head-to-head study of Cervarix and Gardasil for its small sample size, use of... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1215497 Thu, 07 Feb 2008 13:33:03 +0100 1215497 http://www.medworm.com/index.php?rid=1149830&cid=t_91822_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F216553797%2F Another busy Monday morning. We hope yours is going as well as ours. As we track various interesting developments, here are a few more items to help you prepare for the rest of the day… USPTO Rejects Pfizer’s Basic Lipitor Patent (Yahoo/Reuters) France Backs Use Of Merck’s Gardasil Over Glaxo HPV Vaccine (Yahoo/Reuters) Maryland Court Rejects Thimerosal-Autism Link In Wyeth Vaccine (Yahoo/Reuters) Avalon Pharma Signs Development Deal With Novartis (The Baltimore Sun) Share / E-mail (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1149830 Mon, 14 Jan 2008 17:48:36 +0100 1149830 http://www.medworm.com/index.php?rid=989735&cid=t_91822_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F177174813%2Fuk_to_vaccine_school_girls_against_hpv_gks_and_merck_vie_for_contract.html In what can only be seen as a huge bonus for Merck & Co. (NYSE:MRK) and GlaxoSmithKline Plc's (NYSE:GSK) , the U.K government has announced that it will begin vaccinating all girls between the ages of 12 and 13 as of next September against human papilloma virus (HPV).Marketed as Gardasil by Merck and Cervarix by GlaxoKlineSmith, both companies are competing for the government contract to immunize all those British school girls.The vaccine is purported to be most effective on girls who have yet to begin their sexual lives but may also be beneficial to women aged 24 and older depending on their exposure to HPV and their level of sexual activity. The vaccine protects against 70 percent of HPV strains leaving 30% of the HPV strains unprevented and thus leaving a chance f... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=989735 Mon, 29 Oct 2007 21:15:10 +0100 989735 http://www.medworm.com/index.php?rid=982729&cid=t_91822_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F175388616%2F The UK’s Health Minister announced today that, starting in September, girls who are 12 and 13 years old can get vaccinated, although the shots won’t be mandatory. A catch-up campaign to vaccinate girls up to 18 years old will start in 2009. “This is an exciting step towards preventing cervical cancer in the UK,” says Harpal Kumar, Cancer Research UK’s ceo. “Prevention is always better than cure and this vaccine will prevent many women from catching the human papilloma virus in the first place, potentially saving around 400 hundred lives a year,” says health minister Alan Johnson in a statement. But which vaccine? That hasn’t been decided. Both Merck’s Gardasil and Glaxo’s Cervarix are approved in Europe and priced comparably, set... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=982729 Fri, 26 Oct 2007 14:30:52 +0100 982729 http://www.medworm.com/index.php?rid=931170&cid=t_91822_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F165778742%2Fglaxoklein_and_mercks_pr_battl_1.html For the last week or so pharma news has been full of articles headlining either GlaxoSmithKlein's (NYSE:GSK) Cervarix or Merck's (NYSE:MRK) Gardasil. Both are vying for the bigger share of the potential multi-billion cervical cancer pot.It started with GlaxoSmithKlein submitting for marketing approval of Cervarix in Japan, switched to Merck donating 3 million doses of Gardasil to developing countries and went back to Glaxo starting sales in Europe and requesting prequalification from WHO for distribution in developing countries. Then we had Merck winning the Prix Galien for best new biotech product and Sanofi Pasteur filing to extend Gardasil treatments in Europe. (Source: PharmaGazette) PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=931170 Fri, 05 Oct 2007 15:51:22 +0100 931170 http://www.medworm.com/index.php?rid=919096&cid=t_91822_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F164152049%2F And so another day has begun. We hope yours is getting off to a good start. For us, it is a bright beginning - the dog has pooped, the heirs are off to school and the hot coffee is beckoning… Roche has promoted Juergen Schwiezer to head its diagnostics division, replacing Severin Schwan, who becomes ceo on March 4. Schwiezer, 62, who leads the unit in Europe and Latin America, starts on Jan. 1. Franz Humer, the currrent ceo, will remain chairman and Schwan, 40, who joined Roche as finance officer in 1993, will become the youngest ceo to ever run Roche. Glaxo will charge $490 for a full course of Cervarix, its new HPV vaccine, in the UK and Germany, which matches the price set by Merck for Gardasil. The Glaxo vaccine goes on sale in the two countries today, although the European Unio... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=919096 Tue, 02 Oct 2007 10:50:32 +0100 919096 http://www.medworm.com/index.php?rid=903795&cid=t_91822_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F161090204%2F So who was behind Gardasil? A key player was University of Washington epidemiology professor Laura Koutsky (pictured to the left), who’s credited with developing the HPV vaccine along with Kathrin Jansen, a yeast expert then at Merck Research Laboratories. Her studies, published in the New England Journal of Medicine and the American Journal of Epidemiology, examined the disease’s natural history — what causes cervical cancer and HPV, who gets it and when. Without knowing those basics, it would have been impossible to make a vaccine, writes The Seattle Times, which profiles the researcher. After a key clinical trial found that Gardasil worked against a prevalent HPV strain, they had to decide which strains to include in the vaccine that would go to the public. “Everyone... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=903795 Tue, 25 Sep 2007 14:30:15 +0100 903795 http://www.medworm.com/index.php?rid=894335&cid=t_91822_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F160564679%2F And so we all return from the weekend. Hope yours was enjoyable. Ours was splendid. We managed to mow the lawn yesterday, a rare event that met with the approval of the neighbors (not that we care all that much). And we took the shortest of the short people on a hayride to pick a few pumpkins. Now, though, we are again scouring the world for interesting insights. Here are a few of the latest… EU Delays Schering-Plough, Organon Review For Two Weeks (CNNMoney/Dow Jones) EU Approves Pfizer’s Selzentry AIDS Drug (Yahoo/Reuters) Glaxo Wins EU Approval To Sell Cervarix HPV Vaccine (Bloomberg News) Novartis’ Exelon Alzheimer’s Patch Approved By EU (CNN/Thomson Financial) Lilly Sues Sun Pharma To Block Generic Version Of Strattera (Bloomberg News) FDA Delays Approval Of Gla... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=894335 Mon, 24 Sep 2007 11:10:00 +0100 894335 http://www.medworm.com/index.php?rid=574854&cid=t_91822_112_f&fid=34614&url=http%3A%2F%2Fthewelltimedperiod.blogspot.com%2F2007%2F04%2Fgardasil-efficacy-update.html More good news about Gardasil, one of the HPV vaccines:ATLANTA — The efficacy of Gardasil is becoming more apparent over time, Dr. Eliav Barr said at a meeting of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention.Merck is continuing to follow subjects post marketing, with nearly 3 years of data now available from three of the premarketing trials involving more than 18,000 young women.Among those are 2.4 years for the group that was naive to all four vaccine strains of human papillomavirus (6, 11, 16, and 18) at baseline, 2.9 years for another group that was naive to 14 HPV types, and 2.8 years for a combined group of uninfected and infected women at baseline, said Dr. Barr, program head of HPV Vaccines for Merck Research Laboratories, Blue... The Well-Timed Period blogs http://www.medworm.com/rss/comments.php?id=574854 Fri, 27 Apr 2007 17:06:00 +0100 574854 http://www.medworm.com/index.php?rid=396064&cid=t_91822_86_f&fid=34445&url=http%3A%2F%2Fwomenshealthnews.blogspot.com%2F2007%2F02%2Fon-texas-hpv-vaccine-law.html Texas has passed legislation to require all girls ages 11-12 to receive the HPV vaccine before entering 6th grade. Some have responded to this by claiming that the government is taking control away from parents, and that this is simply a money-making venture for Merck, producer of the Gardasil vaccine, the only currently approved HPV vaccine. Merck certainly has a financial interest in having as many girls as possible vaccinated, and this New York Times article suggests the company is actively lobbying state legislatures to require vaccination. However, the executive order signed by the TX Governor makes no specific mention of Merck; it refers only to "HPV vaccine." When other companies get their vaccines (which are already in development) approved, Texas parents and doctors would be able ... Women's Health News blogs http://www.medworm.com/rss/comments.php?id=396064 Sun, 04 Feb 2007 16:28:00 +0100 396064 http://www.medworm.com/index.php?rid=460962&cid=t_91822_112_f&fid=34614&url=http%3A%2F%2Fthewelltimedperiod.blogspot.com%2F2007%2F02%2Fcervical-cancer-drops-but-disparities.html Interesting report on cervical cancer demographics (emphasis mine):NEW YORK (Reuters Health) - In the United States, rates of invasive cervical cancer declined between 1998 and 2002, although significant racial, ethnic, and geographic differences persisted, according to pre-vaccine surveillance data covering 87 percent the population of women.Altogether, 59,848 cases of cervical cancer cases were identified during the 5-year study period. The annual number of cases fell from 12,720 in 1998 to 11,071 in 2002.The incidence rate declined from 10.2 per 100,000 women in 1998 to 8.5 per 100,000 in 2002, report Dr. Mona Saraiya from the Centers for Disease Control and Prevention, Atlanta....For the period as a whole, the average annual incidence rate was highest among Hispanic women (14.8 per 100... The Well-Timed Period blogs http://www.medworm.com/rss/comments.php?id=460962 Thu, 01 Feb 2007 02:43:00 +0100 460962